PMGC’s NorthStrive Biosciences files 10 new U.S. patent applications

NorthStrive Biosciences, a wholly owned subsidiary of PMGC (ELAB) Holdings, announced the filing of ten new U.S. patent applications expanding its proprietary EL-22 and EL-32 technologies into animal health and agricultural markets, including applications designed to encourage animals to grow new muscle and increase muscle weight return per animal. These ten patent applications include five new patent applications covering EL-22 and five new, corresponding applications covering EL-32 across multiple farmed animal categories, including livestock, aquaculture, and poultry.